Skip to content

Collection and Characterization of Objective Measures to Explore the Specificity of Algorithms

Trans-impedance Matrix

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03294681
Enrollment
153
Registered
2017-09-27
Start date
2017-10-03
Completion date
2019-05-29
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Brief summary

The aim of this descriptive study is to collect and describe the characteristics of objective measures to explore the specificity of algorithms.

Interventions

DEVICEObjective measures with CSEP

Objective measures to be conducted with Custom SoundTM EP 5 software and the CP900 series sound processor in CI532 and CI512 Cochlear Implant recipients

Sponsors

Cochlear
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Candidate for cochlear implantation with the CI532 or CI512 devices * 18 years of age or older at the time of enrolment * Normal cochlea anatomy, established via pre-operative Computer Tomography * Willingness to participate in and to comply with all requirements of the protocol

Exclusion criteria

* Prior cochlear implantation in the ear to be implanted * Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array * Abnormal cochlear anatomy on pre-operative Computer Tomography or Magnetic Resonance Imaging * Additional handicaps that would prevent participation in evaluations * Pregnant and breast feeding women, prisoners, or anyone in custody * Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure

Design outcomes

Primary

MeasureTime frameDescription
Specificity (%) of Transimpedance Measurement to Identify Electrode Fold-overat surgery, within one minuteMeasured with Custom SoundTM EP 5. It took one minute to measure all electrodes in surgery. Intraoperative transimpedance measures from 148 ears without fold-overs (as evidenced by radiographic imaging) were analysed to assess the specificity of the algorithm.

Countries

Australia, Germany, Spain

Participant flow

Recruitment details

153 participants were recruited in six centres from 03 October 2017 to 29 May 2019.

Participants by arm

ArmCount
Cochlear Implant Recipients
CI532 and CI512 cochlear implant recipients
152
Total152

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicCochlear Implant Recipients
Age, Continuous58 years
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Australia
9 Participants
Region of Enrollment
Germany
115 Participants
Region of Enrollment
Spain
28 Participants
Sex: Female, Male
Female
79 Participants
Sex: Female, Male
Male
73 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 153
other
Total, other adverse events
0 / 153
serious
Total, serious adverse events
2 / 153

Outcome results

Primary

Specificity (%) of Transimpedance Measurement to Identify Electrode Fold-over

Measured with Custom SoundTM EP 5. It took one minute to measure all electrodes in surgery. Intraoperative transimpedance measures from 148 ears without fold-overs (as evidenced by radiographic imaging) were analysed to assess the specificity of the algorithm.

Time frame: at surgery, within one minute

Population: 148 ears were analyzed from 145 participants (with three bilateral participants providing 148 ears). From the 152 baseline participants, seven were excluded from the analysis: for three participants, no transimpedance data were obtained intra-operatively and for four participants the transimpedance data showed measurement abnormalities.

ArmMeasureValue (NUMBER)
Cochlear Implant RecipientsSpecificity (%) of Transimpedance Measurement to Identify Electrode Fold-over98.6 Percentage of ears

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026